Clinical Trial Update: HEALEY ALS Platform Trial - Regimen I NUZ-001 [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the HEALEY ALS Platform Trial Regimen I NUZ-001 in amyotrophic lateral sclerosis, moving through Phase 2/3 and currently enrolling by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• NUZ-001

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION